Literature DB >> 9109495

Immortalization of human cells and its mechanisms.

M Namba1, K Mihara, K Fushimi.   

Abstract

One of the contributions of in vitro neoplastic transformation studies on human cells is the confirmation that cells become malignant by a multistep process. In this review, we use the term "neoplastic transformation" to indicate that the cells become capable of forming a histologically malignant tumor, that is, one that invades and/or erodes normal tissue and is serially transplantable in a susceptible animal host. Phenotypically, the cells first become immortalized and then neoplastic. If normal human cells do not overcome aging by becoming immortalized, they cannot be neoplastically transformed. However, normal human cells are stringently destined to cellular aging and very rarely become immortalized by oncogenic DNA viruses (SV40, papillomavirus types 16 and 18, adenovirus types 5 and 12), chemicals, X-rays, or spontaneously. Once human cells get immortalized, they relatively easily become neoplastic. Evidence shows that immortalization is a critical step in the neoplastic transformation process of human cells. Therefore, investigation of the mechanisms of immortalization is indispensable in understanding the multistep carcinogenesis of human cells. Although the precise mechanisms of immortalization are unknown at present, data indicate that the p53 cascade appears to be important for the immortalization of human cells. The loss of functions of normal p53 may induce genomic instability, resulting in mutations of some other unknown genes that are more directly involved in the immortalization of human cells. These unknown genes, which are presumably located at chromosomes 1, 4, 6, 7, 9, 11, 13, 17, 18, and X are now under extensive investigation.

Entities:  

Mesh:

Year:  1996        PMID: 9109495     DOI: 10.1615/critrevoncog.v7.i1-2.20

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  8 in total

1.  Establishment and characterization of a rat pepsin-producing gastric cell line (OUMS-37)

Authors:  H Pu; C Gao; T Yuasa; M Namba; A Kondo; K Inada; M Sakaguchi
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-10       Impact factor: 2.416

2.  Microtubule breakage is not a major mechanism for resolving end-to-end chromosome fusions generated by telomere dysfunction during the early process of immortalization.

Authors:  W Deng; S W Tsao; X-Y Guan; A L M Cheung
Journal:  Chromosoma       Date:  2007-08-28       Impact factor: 4.316

3.  Effects of MAP kinase inhibitors on epidermal growth factor-induced neoplastic transformation of human keratinocytes.

Authors:  Hideya Mizuno; Yong-Yeon Cho; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  Mol Carcinog       Date:  2006-01       Impact factor: 4.784

4.  Relationship between contact inhibition and intranuclear S100C of normal human fibroblasts.

Authors:  M Sakaguchi; M Miyazaki; Y Inoue; T Tsuji; H Kouchi; T Tanaka; H Yamada; M Namba
Journal:  J Cell Biol       Date:  2000-06-12       Impact factor: 10.539

5.  Regulation of spindle integrity and mitotic fidelity by BCCIP.

Authors:  S C Huhn; J Liu; C Ye; H Lu; X Jiang; X Feng; S Ganesan; E White; Z Shen
Journal:  Oncogene       Date:  2017-04-10       Impact factor: 9.867

6.  Chromosomal instability drives convergent and divergent evolution toward advantageous inherited traits in mammalian CHO bioproduction lineages.

Authors:  Steve Huhn; Meiping Chang; Amit Kumar; Ren Liu; Bo Jiang; Michael Betenbaugh; Henry Lin; Gregg Nyberg; Zhimei Du
Journal:  iScience       Date:  2022-03-14

Review 7.  Human hepatocyte carcinogenesis (review).

Authors:  Hidenori Shiraha; Kazuhide Yamamoto; Masayoshi Namba
Journal:  Int J Oncol       Date:  2013-02-19       Impact factor: 5.650

8.  Establishment, immortalisation and characterisation of pteropid bat cell lines.

Authors:  Gary Crameri; Shawn Todd; Samantha Grimley; Jennifer A McEachern; Glenn A Marsh; Craig Smith; Mary Tachedjian; Carol De Jong; Elena R Virtue; Meng Yu; Dieter Bulach; Jun-Ping Liu; Wojtek P Michalski; Deborah Middleton; Hume E Field; Lin-Fa Wang
Journal:  PLoS One       Date:  2009-12-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.